The UAE healthy future study: a pilot for a prospective cohort study of 20,000 United Arab Emirates nationals.
Abdulle A., Alnaeemi A., Aljunaibi A., Al Ali A., Al Saedi K., Al Zaabi E., Oumeziane N., Al Bastaki M., Al-Houqani M., Al Maskari F., Al Dhaheri A., Shah SM., Loney T., El-Sadig M., Oulhaj A., Wareth LA., Al Mahmeed W., Alsafar H., Hirsch B., Al Anouti F., Yaaqoub J., Inman CK., Al Hamiz A., Al Hosani A., Haji M., Alsharid T., Al Zaabi T., Al Maisary F., Galani D., Sprosen T., El Shahawy O., Ahn J., Kirchhoff T., Ramasamy R., Schmidt AM., Hayes R., Sherman S., Ali R.
BACKGROUND: The United Arab Emirates (UAE) is faced with a rapidly increasing burden of non-communicable diseases including obesity, diabetes, and cardiovascular disease. The UAE Healthy Future study is a prospective cohort designed to identify associations between risk factors and these diseases amongst Emiratis. The study will enroll 20,000 UAE nationals aged ≥18 years. Environmental and genetic risk factors will be characterized and participants will be followed for future disease events. As this was the first time a prospective cohort study was being planned in the UAE, a pilot study was conducted in 2015 with the primary aim of establishing the feasibility of conducting the study. Other objectives were to evaluate the implementation of the main study protocols, and to build adequate capacity to conduct advanced clinical laboratory analyses. METHODS: Seven hundred sixty nine UAE nationals aged ≥18 years were invited to participate voluntarily in the pilot study. Participants signed an informed consent, completed a detailed questionnaire, provided random blood, urine, and mouthwash samples and were assessed for a series of clinical measures. All specimens were transported to the New York University Abu Dhabi laboratories where samples were processed and analyzed for routine chemistry and hematology. Plasma, serum, and a small whole blood sample for DNA extraction were aliquoted and stored at -80 °C for future analyses. RESULTS: Overall, 517 Emirati men and women agreed to participate (68% response rate). Of the total participants, 495 (95.0%), 430 (82.2%), and 492 (94.4%), completed the questionnaire, physical measurements, and provided biological samples, respectively. CONCLUSIONS: The pilot study demonstrated the feasibility of recruitment and completion of the study protocols for the first large-scale cohort study designed to identify emerging risk factors for the major non-communicable diseases in the region.